The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
Sign Up to like & getrecommendations! Published in 2019 at "Movement Disorders"
DOI: 10.1002/mds.27718
Abstract: We recently demonstrated that NLY01, a novel glucagon‐like peptide‐1 receptor agonist, exerts neuroprotective effects in two mouse models of PD in a glia‐dependent manner. NLY01 prevented microglia from releasing inflammatory mediators known to convert astrocytes… read more here.
Keywords: avenues pharmacological; paradigm new; new avenues; neurodegeneration ... See more keywords